Intuity Medical Increases Series 3 Funding to $55M With an Additional Close of $15M

The additional financing will help fund the infrastructure build and commercial launch of Intuity Medical’s POGO AutomaticTM Blood Glucose Monitoring System, the first fully-integrated blood glucose monitor SUNNYVALE, Calif., January 5, 2017– Intuity Medical, Inc., a privately-held company developing innovative technologies for diabetes management, announced today that it has closed an additional $15 million, which brings the total Series 3 equity financing for the company to $55 million.